Blog & Articles

What Side Effects Can I Expect When Using Taxotere?

Taxotere is a chemotherapy drug used to treat breast cancer. The chemotherapy medication is also approved to treat other cancers, including advanced stomach cancer, non-small cell lung cancer, neck cancer, metastatic prostate cancer, and head cancer. Taxotere is administered through an IV because there is no pill form of the drug available.

Some patients have suffered severe side effects after using Taxotere, including permanent hair loss. If you have suffered permanent hair loss after using Taxotere, call our office at 1-866-FOX-FIRM to schedule a free consultation with a Taxotere lawsuit attorney.

Why Should I Hire a Pharmaceutical Litigation Attorney?

If you were injured in a car accident or a slip and fall accident, you would seek the advice of an experienced personal injury attorney who focuses his practice on these types of injury cases. Therefore, you should seek the advice and guidance of a pharmaceutical attorney if you believe that a drug has caused an adverse condition or injury.

What are the Dangerous Side Effects of Xarelto?

Xarelto is a prescription medication used to reduce the risk of strokes and blood clots for some patients. In some cases, Xarelto is an effective medication for people with deep vein thrombosis, irregular heart rate, pulmonary embolism, or atrial fibrillation.  The drug is also used to prevent blood clots from forming in the lungs and legs after knee or hip surgery.

However, for some patients, Xarelto has been known to cause uncontrolled bleeding or internal hemorrhaging. It is very important that if you or your loved one has experienced health issues after using Xarelto that you contact the pharmaceutical litigation attorneys of The Fox Law Firm. We can help you understand your legal rights and options for pursuing a personal injury claim against the makers of Xarelto. Call 1-866-FOX-FIRM for your free case evaluation right now.

Can I Still File a Pradaxa Lawsuit?

Pradaxa is a blood thinner used to treat many conditions. However, as with many blood thinners, when Pradaxa was approved for marketing to consumers, the blood thinner did not have an antidote. Most blood thinners have an antidote in case of emergency or excessive bleeding. For instance, a Vitamin K shot reverses the effects of Warfarin.

Are You at Risk for Ketoacidosis If You Are Taking Invokana?

A study published in the New England Journal of Medicine last year found that Invokana and diabetes drugs like Invokana could double the risk of ketoacidosis for patients. The study compared diabetic patients who utilized a DPP-4 inhibitor versus diabetic patients using SGLT2 inhibitors like Invokana. One of the study’s authors admitted that the doubled risk “sounds frightening.” The risk of ketoacidosis totaled five to eight patients out of every 1,000 patients taking an SGLT2 inhibitor.  

I Cannot Afford to Hire a Defective Drug Attorney, but I Need Help!

When your doctor prescribes a medication, you should be able to trust that the medication is going to perform as expected if you take the medication as directed. Your doctor should inform you of the potential side effects and the labeling and information provided with the medication should also inform you of potential side effects and risks from using the medication.

Because each person’s body and health condition are unique, drugs can react in different ways for different people. For this reason, drug companies have a duty to test drugs to ensure they are safe and effective, but also to identify potential side effects.  Those side effects are disclosed so that patients can make an informed decision with their physician about whether to use the medication.

Can We Trust a Medical Study or Medical Article?

A disturbing study found that some medical and scientific articles have been written by ghostwriters hired by pharmaceutical companies who may have a vested interest in the content of the articles. Medical-ghostwriting could mean that someone with a medical background is assisting the author of the article with the writing or it could be an employee of a company with a vested interest in the material. In some cases, the ghostwriter could be someone with very little medical background who understands how to “turn a phrase” to make something sound one way or another.

How Do Dangerous Drugs Get on The Market?

Many of our clients want to know how dangerous drugs make it to store shelves and pharmacies across the nation. The answer is quite simple. Simply because a drug is approved for sale by the Food and Drug Administration (FDA) that does not mean that the drug is 100 percent safe.

A drug can have potentially dangerous side effects and still make it to market. Even when the FDA is notified of a problem, it might not pull the drug from the market. Hundreds of Safety Alerts have been issued for drugs warning doctors and consumers of potentially dangerous and deadly side effects. In some cases, the FDA might require a drug company to place enhanced warnings on the packaging or materials, but not take the drug off the market.

Talcum Powder and Ovarian Cancer

The talcum powder ovarian cancer lawsuits are proceeding against Johnson & Johnson. Claims against the company allege that it failed to provide adequate warnings that the use of talcum-based products could increase the risk of developing ovarian cancer. Product liability attorneys, including our defective product attorneys, continue to review claims of potential plaintiffs of injuries sustained because they used products containing talcum powder such as Shower-to-Shower, baby powder, and body powder.

What Do I Need to File an Essure Lawsuit?

In October of 2017, three members of Congress sent a letter to Commissioner Gottlieb of the Food and Drug Administration (FDA) about Essure. The Congress members expressed concerns about the FDA’s “inaction on the dangerous medical device Essure.”  According to the letter, the FDA mandated that Bayer, the manufacturer of the Essure birth control device, conduct an additional safety study. However, after a year and a half, it is still unclear whether Bayer acted with any urgency to enroll patients or if the study results are delayed.